Personal genetic testing firm 23andMe has hired Jill Hagenkord as its chief medical officer. She will be the company's liaison to physician, medical, genetics and research industry groups, and oversee laboratory operations.
Before joining 23andMe, Hagenkord was senior VP of medical strategy for InVitae, another genetics firm. She has subspecialty training in both pathology/oncology informatics and molecular genetic pathology.
Bio-Reference Laboratories announced that Robert Daber has taken on a dual role at the company's Elmwood Park, NJ, headquarters as director of research and development and director of cancer genetics. Before joining Bio-Reference Laboratories, Daber was technical director of clinical genetics at the University of Philadelphia.